Gaidzik, V I <br/><br/>
DNMT3A mutant transcript levels persist in remission and do not predict outcome in patients with acute myeloid leukemia.  [electronic resource] 

 -  Leukemia  01 2018 
 - 30-37 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5551 
<br/><br/><label>Standard No.: </label>10.1038/leu.2017.200  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>DNA (Cytosine-5-)-Methyltransferases--genetics<br/>DNA Methyltransferase 3A<br/>Female<br/>Hematopoiesis--genetics<br/>Humans<br/>Leukemia, Myeloid, Acute--genetics<br/>Male<br/>Middle Aged<br/>Mutation<br/>Neoplasm, Residual--genetics<br/>Prognosis<br/>Young Adult